Macquarie Group’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-80,000
Closed -$2.88M 1320
2025
Q3
$2.88M Hold
80,000
﹤0.01% 1074
2025
Q2
$2.6M Sell
80,000
-109,793
-58% -$3.6M ﹤0.01% 1148
2025
Q1
$7.17M Sell
189,793
-58,241
-23% -$4.66M 0.01% 888
2024
Q4
$20.3M Buy
248,034
+39,159
+19% +$3.89M 0.02% 649
2024
Q3
$23.9M Buy
208,875
+49,863
+31% +$4.49M 0.03% 625
2024
Q2
$12M Buy
+159,012
New +$10.8M 0.01% 777
2022
Q4
Hold
0
-$22K 2196
2022
Q3
Sell
-928
Closed -$23.5K 2172
2022
Q2
$20K Hold
928
﹤0.01% 2309
2022
Q1
$22 Hold
928
﹤0.01% 2369
2021
Q4
$22K Sell
928
-1,064
-53% -$24.7K ﹤0.01% 2375
2021
Q3
$51K Hold
1,992
﹤0.01% 2231
2021
Q2
$45K Buy
+1,992
New +$40.8K ﹤0.01% 2178

Other funds holding PCVX